OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenImmigration
  • OpenLobby
  • VaccineWatch
  • OpenSubsidies
  • WarCosts
  • OpenPrescriber

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid · OpenFeds · OpenSpending · OpenImmigration · OpenLobby · VaccineWatch · OpenSubsidies · WarCosts

© 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodology•Download Data
  1. Home
  2. Providers
  3. Tarek Sousou
🎗️
MDIndividual

Tarek Sousou, MD

NPI: 1588776264
East Syracuse, NY
10 years of data
Hematology-Oncology
$20.9M
Total Payments
507
Beneficiaries
1.9M
Services
2.97x
Markup Ratio

Peer Comparison

99th
percentile in specialty
This provider$20.9M
Specialty median$339.6K

📋 Key Findings

1Billed $20.9M over 10 years
22.97x markup ratio (above median)
399th percentile in Hematology-Oncology by payments
4776 services/day — physically implausible
5Payments surged 115% in 2015
66 procedures with >3x markup

⚠️ This provider averages 776 services per working day — physically unusual for an individual practitioner

Based on 1.9M total services over 10 years (250 working days/year). Learn about impossible service volumes →

🔎 Data Analysis

This provider's $20.9M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.

Averaging 776 services per working day raises questions about billing patterns.

Medicare payments to this provider grew 766% from 2014 to 2023.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

📈

Notable: Payments increased 115% in 2015

Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2014$27.70$7.973.48x$19.73$489.5K61.4K35
2015$28.91$8.073.58x$20.84$1.1M130.4K52
2016$34.97$10.843.23x$24.13$1.7M156.5K57
2017$29.00$9.513.05x$19.49$1.9M198.6K51
2018$24.73$8.312.98x$16.42$1.7M210.2K48
2019$31.54$10.802.92x$20.74$1.9M178.3K47
2020$31.55$11.032.86x$20.52$1.7M152.1K51
2021$33.29$11.142.99x$22.15$2.9M258.6K54
2022$35.02$12.712.76x$22.31$3.3M262.6K55
2023$36.45$12.832.84x$23.62$4.2M330.5K57

Top Procedures (20)

J9271Injection, pembrolizumab, 1 mg
$3.8M
98.0K services$38.94/svc2.28x markup
J9299Injection, nivolumab, 1 mg
$2.4M
110.2K services$21.74/svc2.71x markup
J2505Injection, pegfilgrastim, 6 mg
$1.5M
511 services$2.9K/svc2.53x markup
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
$1.4M
41.5K services$33.40/svc2.60x markup
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj
$1.4M
37.1K services$36.85/svc2.31x markup
J0897Injection, denosumab, 1 mg
$846.8K
54.3K services$15.60/svc2.68x markup
J9041Injection, bortezomib, 0.1 mg
$817.2K
27.4K services$29.85/svc2.61x markup
J9310Injection, rituximab, 100 mg
$666.5K
1.1K services$620.61/svc2.13x markup
G9678Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
$600.8K
3.8K services$157.83/svc1.06x markup
J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)⚠ 4.4x markup
$487.1K
171.5K services$2.84/svc4.37x markup
99214Established patient office or other outpatient visit, 30-39 minutes
$476.9K
5.8K services$81.86/svc2.66x markup
96413Administration of chemotherapy into vein, 1 hour or less⚠ 3.3x markup
$461.8K
4.5K services$102.64/svc3.32x markup
J9022Injection, atezolizumab, 10 mg
$459.2K
7.2K services$63.99/svc2.22x markup
J9305Injection, pemetrexed, not otherwise specified, 10 mg⚠ 3.9x markup
$367.3K
11.3K services$32.56/svc3.88x markup
J9173Injection, durvalumab, 10 mg
$360.4K
5.8K services$62.22/svc2.22x markup
J0885Injection, epoetin alfa, (for non-esrd use), 1000 units⚠ 3.9x markup
$305.1K
34.9K services$8.75/svc3.85x markup
99213Established patient office or other outpatient visit, 20-29 minutes
$271.8K
4.9K services$55.23/svc2.65x markup
Q5119Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg⚠ 3.5x markup
$232.3K
6.0K services$38.66/svc3.50x markup
74177Ct scan of abdomen and pelvis with contrast⚠ 3.8x markup
$206.9K
1.3K services$165.39/svc3.75x markup
J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
$185.6K
1.7K services$108.03/svc2.95x markup
Show detailed table ▾
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
J9271Injection, pembrolizumab, 1 mg98.0K$3.8M$38.942.28x
J9299Injection, nivolumab, 1 mg110.2K$2.4M$21.742.71x
J2505Injection, pegfilgrastim, 6 mg511$1.5M$2.9K2.53x
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg41.5K$1.4M$33.402.60x
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj37.1K$1.4M$36.852.31x
J0897Injection, denosumab, 1 mg54.3K$846.8K$15.602.68x
J9041Injection, bortezomib, 0.1 mg27.4K$817.2K$29.852.61x
J9310Injection, rituximab, 100 mg1.1K$666.5K$620.612.13x
G9678Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a3.8K$600.8K$157.831.06x
J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)171.5K$487.1K$2.844.37x
99214Established patient office or other outpatient visit, 30-39 minutes5.8K$476.9K$81.862.66x
96413Administration of chemotherapy into vein, 1 hour or less4.5K$461.8K$102.643.32x
J9022Injection, atezolizumab, 10 mg7.2K$459.2K$63.992.22x
J9305Injection, pemetrexed, not otherwise specified, 10 mg11.3K$367.3K$32.563.88x
J9173Injection, durvalumab, 10 mg5.8K$360.4K$62.222.22x
J0885Injection, epoetin alfa, (for non-esrd use), 1000 units34.9K$305.1K$8.753.85x
99213Established patient office or other outpatient visit, 20-29 minutes4.9K$271.8K$55.232.65x
Q5119Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg6.0K$232.3K$38.663.50x
74177Ct scan of abdomen and pelvis with contrast1.3K$206.9K$165.393.75x
J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg1.7K$185.6K$108.032.95x

Markup Analysis

Charge-to-Payment Ratio

2.97x

This provider submits charges 2.97 times higher than what Medicare actually pays.

What This Means

A markup ratio of 2.97x means for every $100 Medicare pays, this provider initially charges $297. This is higher than the national average.

Location

East Syracuse, NY

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Related

Browse
← Back to Provider Directory
State
All providers in NY →
Specialty
All Hematology-Oncology providers →
Tool
Compare this provider →
Analysis
Fraud Watchlist →
Search
Search all providers →

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • • Centers for Medicare & Medicaid Services (CMS)
  • • Medicare Provider Utilization and Payment Data (2014-2023)
  • • National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data